Skip to main content

Psoriasis Vulgaris and Arthopathica

  • Chapter
Autoimmune Diseases of the Skin
  • 1312 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbas AK, Murphy KM, and Sher A (1996) Functional diversity of helper T lymphocytes. Nature, 383: 787–793

    Article  PubMed  Google Scholar 

  • Adam O (1995) Anti-inflammatory diet in rheumatic diseases. Eur J Clin Nutr, 49: 703–717

    PubMed  Google Scholar 

  • Arias A, Giles B, Eiermann T, Sterry W, and Pandey J (1997) Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet, 14: 118–122

    PubMed  Google Scholar 

  • Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, and Docke WD (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest, 101: 783–794

    PubMed  Google Scholar 

  • Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, and Sterry W (2001) Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol, 116: 975–978

    Article  PubMed  Google Scholar 

  • Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, Moser M, de Cid R, Ripatti S, Vorechovsky I, Marcusson J, Nakagawa H, Lazaro C, Estivill X, Capon F, Novelli G, Saarialho Kere U, Barker J, Trembath R, and Kere J (2002) Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum Mol Genet, 11: 589–597

    Article  PubMed  Google Scholar 

  • Baker BS, Powles AV, Malkani AK, Lewis H, Valdimarsson H, and Fry L (1991) Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasis. Br J Dermatol, 125: 38–42

    PubMed  Google Scholar 

  • Baker BS, Bolith S, Powles AV, Valdimarsson H, and Fry L (1992) Streptococcal antigen-specific T lymphocytes in skin lesions of guttate psoriasis. J Invest Dermatol, 98: 535–538

    Google Scholar 

  • Bata-Csorgo Z, Hammerberg C, Voorhees JJ, and Cooper KD (1995) Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest, 95: 317–327

    PubMed  Google Scholar 

  • Bos JD, Hulsebosch HJ, Krieg SR, Bakker PM, and Cormane RH (1983) Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res, 275: 181–189

    Article  PubMed  Google Scholar 

  • Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, and Kapsenberg ML (1989) Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res, 281: 24–30

    Article  PubMed  Google Scholar 

  • Bowcock A, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez Vina M, and Menter A (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet, 10: 1793–1805

    Article  PubMed  Google Scholar 

  • Brandrup F, Holm N, Grunnet N, Henningsen K, and Hansen HE (1982) Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol, 62: 229–236

    PubMed  Google Scholar 

  • Braun-Falco O and Christophers E (1974) Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch, 251: 95–110

    PubMed  Google Scholar 

  • Chang JCC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinson DI, Carlo DJ, and Brostoff SW (1994) CD8+T cells in psoriatic lesions preferentially use T-cell receptor V?3 and/orV?13.1 genes. Proc Natl Acad Sci USA, 91: 9282–9286

    PubMed  Google Scholar 

  • Chang JC, Smith LR, Froning KJ, Kurland HH, Schwabe BJ, Blumeyer KK, Karasek MA, Wilkinson DI, Farber EM, Carlo DJ, and Brostoff SW (1997) Persistence of T-cell clones in psoriatic lesions. Arch Dermatol, 133: 703–708

    Article  PubMed  Google Scholar 

  • Christophers E and Henseler T (1985) Characterization of disease patterns in nonpustular psoriasis. Semin Dermatol, 4: 271–275

    Google Scholar 

  • Cookson W, Ubhi B, Lawrence R, Abecasis G, Walley A, Cox H, Coleman R, Leaves N, Trembath R, Moffatt M, and Harper J (2001) Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet, 27: 372–373

    Article  PubMed  Google Scholar 

  • Dirckx JH (1983) Dermatologic terms in the De Medicina of Celsus. Am J Dermatopathol, 5: 363–369

    Google Scholar 

  • Edlund E, Johnsson U, Lidgren L, Pettersson H, Sturfelt G, Svensson B, Theander J, and Willen H (1988) Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis, 47: 809–815

    PubMed  Google Scholar 

  • Elder J, Nair R, Henseler T, Jenisch S, Stuart P, Chia N, Christophers E, and Voorhees J (2001) The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol, 137: 1447–1454

    PubMed  Google Scholar 

  • Farber EM, Nall ML, and Watson W (1974) Natural history of psoriasis in 61 twin pairs. Arch Dermatol, 109: 207–211

    PubMed  Google Scholar 

  • Farber EM (1992) History of the treatment of psoriasis. J Am Acad Dermatol, 27: 640–645

    PubMed  Google Scholar 

  • Fujinami RS and Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science, 230: 1043–1045

    PubMed  Google Scholar 

  • Glickman FS (1986) Lepra, psora, psoriasis. J Am Acad Dermatol, 14: 863–866

    PubMed  Google Scholar 

  • Gonzalez S, Martinez Borra J, Torre Alonso J, Gonzalez Roces S, Sanchez del Rio J, Rodriguez Perez A, Brautbar C, and Lopez Larrea C (1999) The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum, 42: 1010–1016

    Article  PubMed  Google Scholar 

  • Gordon M and Johnson WC (1967) Histopathology and histochemistry of psoriasis. I. The active lesion and clinically normal skin. Arch Dermatol, 95: 402–407

    Article  PubMed  Google Scholar 

  • Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, and Krueger JG (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med, 1: 442–447

    Article  PubMed  Google Scholar 

  • Gudjonsson J, Karason A, Antonsdottir A, Runarsdottir E, Hauksson V, Upmanyu R, Gulcher J, Stefansson K, and Valdimarsson H (2003) Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol, 148: 233–235

    PubMed  Google Scholar 

  • Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, Good MF, Valdimarsson H, and Jonsdottir I (1999) Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol, 117: 580–586

    Article  PubMed  Google Scholar 

  • Halpern SM, Anstey AV, Dawe RS, Diffey BL, Farr PM, Ferguson J, Hawk JL, Ibbotson S, McGregor JM, Murphy GM, Thomas SE, and Rhodes LE (2000) Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol, 142: 22–31

    Article  PubMed  Google Scholar 

  • Harder J, Bartels J, Christophers E, and Schroder JM (1997) A peptide antibiotic from human skin. Nature, 387: 861

    Article  PubMed  Google Scholar 

  • Harvima IT, Naukkarinen A, Harvima RJ, and Horsmanheimo M (1989) Enzyme-and immunohistochemical localization of mast cell tryptase in psoriatic skin. Arch Dermatol Res, 281: 387–391

    Article  PubMed  Google Scholar 

  • Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JAW, Robarge J, Ott J, Kwok P-Y, Menter A, and Bowcock AM (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet, 35: 349–356

    Article  PubMed  Google Scholar 

  • Henseler T (1997) The genetics of psoriasis. J Am Acad Dermatol, 37: S1–11

    Google Scholar 

  • Henseler T (1998) Genetics of psoriasis. Arch Dermatol Res, 290: 463–476

    Article  PubMed  Google Scholar 

  • Homey B, Alenius H, Muller A, Soto H, Bowman E, Yuan W, McEvoy L, Lauerma A, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, and Zlotnik A (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med, 8: 157–165

    Article  PubMed  Google Scholar 

  • Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H, Miyazaki M, Nakajima N, Okada M, and Saito T (2002) Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J Immunol, 168: 541–544

    PubMed  Google Scholar 

  • Jenisch S, Koch S, Henseler T, Nair RP, Elder JT, Watts CE, Westphal E, Voorhees JJ, Christophers E, and Kronke M (1999) Corneodesmosin gene polymorphism demonstrates strong linkage disequilibrium with HLA and association with psoriasis vulgaris. Tissue Antigens, 54: 439–449

    Article  PubMed  Google Scholar 

  • Kagi MK, Wüthrich B, Montano E, Baradun J, Blaser K, and Walker C (1994) Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol, 103: 332–340

    PubMed  Google Scholar 

  • Koo J and Lebwohl M (1999) Duration of remission of psoriasis therapies. J Am Acad Dermatol, 41: 51–59

    PubMed  Google Scholar 

  • Leach D and Beckwith J (1999) The founders of dermatology: Robert Willan and Thomas Bateman. J R Coll Physicians Lond, 33: 580–582

    PubMed  Google Scholar 

  • Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, and Weinstein G (1998) Cyclosporine consensus conference: with emphasis on the treatment of psoriasis [see comments]. J Am Acad Dermatol, 39: 464–475

    PubMed  Google Scholar 

  • Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, and Bunker C (2000) HLA-C and guttate psoriasis. Br J Dermatol, 143: 1177–1182

    PubMed  Google Scholar 

  • McCarty, M. 1973, Host-parasite relations in bacterial diseases: Davis, B. D., Dulbecco, R., Eisen, H. N., Ginsberg, H. S., Wood, W. B., and McCarty, M. v. 2nd, (22):p. 627–665. Microbiology. Harper & Row: Hagerstown, New York, Evanstown, San Francisco, London

    Google Scholar 

  • Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, Gürtler L, Riethmüller G, and Prinz JC (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol, 155: 4078–4083

    PubMed  Google Scholar 

  • Michel G, Kemény L, Homey B, and Ruzicka T (1996) FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today, 17: 106–108

    Article  PubMed  Google Scholar 

  • Moll JM and Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum, 3: 55–78

    Article  PubMed  Google Scholar 

  • Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, Lebwohl M, Lew R, Naldi L, Parrish JA, Piepkorn M, Stern RS, Weinstein GD, and Whitmore SE (1998) Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol, 134: 595–598

    Article  PubMed  Google Scholar 

  • Mrowietz U, Christophers E, and Altmeyer P (1999) Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol, 141: 424–429

    Article  PubMed  Google Scholar 

  • Mueller W and Hermann B (1976) Cyclosporin A for psoriasis. N Engl J Med, 301: 355

    Google Scholar 

  • Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, and Elder JT (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet, 6: 1349–1356

    Article  PubMed  Google Scholar 

  • Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, and Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet, 66: 1833–1844

    Article  PubMed  Google Scholar 

  • Nickoloff BJ, Karabin GD, and Barker JNWN (1991) Localization of IL-8 and its inducer TNF-? in psoriasis. Am J Pathol, 138: 129–140

    PubMed  Google Scholar 

  • Nicolas JF, Chamchick N, Thivolet J, Wijdenes J, Morel P, and Revillard P (1991) CD4 antibody treatment of severe psoriasis. Lancet, 338: 321

    Article  Google Scholar 

  • Norrlind R (1954) Significance of infections in origination of psoriasis. Acta Rheum Scand, 1: 135–140

    Google Scholar 

  • Oldstone MB (1987) Molecular mimicry and autoimmune disease. Cell, 50: 819–820

    Article  PubMed  Google Scholar 

  • Pinkus H and Mehregan AH (1966) The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol, 46: 109–116

    PubMed  Google Scholar 

  • Prinz JC, Braun-Falco O, Meurer M, Daddona P, Reiter C, Rieber EP, and Riethmüller G (1991) Chimeric CD4 monoclonal antibody in the treatment of generalized pustular psoriasis. Lancet, 338: 320–321

    Google Scholar 

  • Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, and Plewig G (1994) T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro. Eur J Immunol, 24: 593–598

    PubMed  Google Scholar 

  • Prinz JC, Vollmer S, Boehncke W-H, Menssen A, Laisney I, and Trommler P (1999) Selection of conserved TCR-VDJ-rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol, 29: 3360–3368

    Article  PubMed  Google Scholar 

  • Prinz JC (2003) The role of T cells in psoriasis. J Eur Ac Derm Venerol, 17: 257–270

    Article  Google Scholar 

  • Prinz JC (2004) Disease mimicry: A pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry? Autoimmun Rev, 3: 10–15

    PubMed  Google Scholar 

  • Prodeus AP, Zhou X, Maurer M, Galli SJ, and Carroll MC (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature, 390: 172–175

    Article  PubMed  Google Scholar 

  • Prokunina L, Castillejo Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes A, Tentler D, Kristjansdottir H, Grondal G, Bolstad A, Svenungsson E, Lundberg I, Sturfelt G, Jonssen A, Truedsson L, Lima G, Alcocer Varela J, Jonsson R, Gyllensten U, Harley J, Alarcon Segovia D, Steinsson K, and Alarcon Riquelme M (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet, 32: 666–669

    Article  PubMed  Google Scholar 

  • Queiro R, Torre J, Gonzalez S, Lopez Larrea C, Tinture T, and Lopez Lagunas I (2003) HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. J Rheumatol, 30: 505–507

    PubMed  Google Scholar 

  • Ragaz A and Ackerman AB (1979) Evolution, maturation, and regression of lesions of psoriasis. New observations and correlation of clinical and histologic findings. Am J Dermato-pathol, 1: 199–214

    Google Scholar 

  • Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr., and Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol, 41: 401–407

    PubMed  Google Scholar 

  • Reczek D, Berryman M, and Bretscher A (1997) Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol, 139: 169–179

    Article  PubMed  Google Scholar 

  • Reich K, Mossner R, Konig I, Westphal G, Ziegler A, and Neumann C (2002) Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-lbeta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol, 118: 155–163

    Article  PubMed  Google Scholar 

  • Robinson JH and Kehoe MA (1992) Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today, 13: 362–367

    PubMed  Google Scholar 

  • Roenigk HH, Jr., Auerbach R, Maibach H, Weinstein G, and Lebwohl M (1998) Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol, 38: 478–485

    PubMed  Google Scholar 

  • Russel TJ, Schultes LM, and Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med, 287: 738–740

    PubMed  Google Scholar 

  • Schaible UE, Collins HL, and Kaufmann SH (1999) Confrontation between intracellular bacteria and the immune system. Adv Immunol, 71: 267–377

    PubMed  Google Scholar 

  • Schmitt Egenolf M, Eiermann TH, Boehncke WH, Stander M, and Sterry W (1996) Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1 *0701-DQA1 *0201-DQB1 *0303: a population and family-based study. J Invest Dermatol, 106: 711–714

    Article  PubMed  Google Scholar 

  • Schroder JM and Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol, 31: 645–651

    Article  PubMed  Google Scholar 

  • Shelley WB and Kirschbaum JO (1961) Generalized pustular psoriasis. Arch Dermatol, 84: 73–78

    PubMed  Google Scholar 

  • Sigmundsdottir H, Sigurgeirsson B, Troye Blomberg M, Good MF, Valdimarsson H, and Jonsdottir I (1997) Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins. Scand J Immunol, 45:688–697

    Article  PubMed  Google Scholar 

  • Tazi Ahnini R, Camp NJ, Cork MJ, Mee JB, Keohane SG, Duff GW, and di Giovine FS (1999) Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum Mol Genet, 8: 1135–1140

    Article  PubMed  Google Scholar 

  • Tervaert WC and Esseveld H (1970) A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica, 140: 282–290

    PubMed  Google Scholar 

  • Tokuhiro A, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, and Yamamoto K (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet, 35: 341–348

    Article  PubMed  Google Scholar 

  • Tomfohrde J, Silverman A, Barnes R, Fernandez Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, and et al (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science, 264: 1141–1145

    PubMed  Google Scholar 

  • Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, and Barker JN (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet, 6: 813–820

    Article  PubMed  Google Scholar 

  • Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Fujita H, Asano N, Kishimoto M, Tanida Y, Kakinuma T, Mitsui H, Tada Y, Wakugawa M, Torii H, Komine M, Asahina A, and Tamaki K (2002) Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci, 30: 161–166

    Article  PubMed  Google Scholar 

  • Valdimarsson H, Baker BS, Jonsdottir I, and Fry L (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today, 7: 256–259

    Article  Google Scholar 

  • Valdimarsson H, Sigmundsdottir H, and Jonsdottir I (1997) Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol, 107Suppl 1: 21–24

    Article  Google Scholar 

  • Vollmer S, Menssen A, Trommler P, Schendel D, and Prinz JC (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol, 24: 2377–2382

    PubMed  Google Scholar 

  • Weinshenker BG, Bass BH, Ebers GC, and Rice GP (1989) Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. J Am Acad Dermatol, 20: 1132–1133

    PubMed  Google Scholar 

  • Weisenseel P, Laumbacher B, Besgen P, Ludolph-Hauser D, Herzinger T, Roecken M, Wank R, and Prinz JC (2002) Streptococcal infection distinguishes different types of psoriasis. J Med Genet, 39: 767–768

    Article  PubMed  Google Scholar 

  • Zhou X, Krueger J, Kao M, Lee E, Du F, Menter A, Wong W, and Bowcock A (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics, 13: 69–78

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Wien

About this chapter

Cite this chapter

Prinz, J.C. (2005). Psoriasis Vulgaris and Arthopathica. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/3-211-27377-8_14

Download citation

  • DOI: https://doi.org/10.1007/3-211-27377-8_14

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-20686-7

  • Online ISBN: 978-3-211-27377-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics